Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



The Oxford Science Park: Immunometabolism company Sitryx expands into new space at TOSP

Sitryx, a company which is focused on regulating cell metabolism to develop disease-modifying therapeutics in inflammatory diseases and immuno-oncology, announces that it has expanded into new premises in the Bellhouse Building at The Oxford Science Park (TOSP), one of the UK’s leading parks for science and technology companies.

Read the rest of entry »

The Oxford Trust: £0.5 million Headington life science laboratory development at The Oxford Trust’s Innovation Centre supported by funding secured by OxLEP

The Oxford Trust, the local charity encouraging the pursuit of science and enterprise, is to undertake a half million-pound project to install life science laboratory facilities at its Wood Centre for Innovation in Headington, Oxford, to increase capacity for the local innovation ecosystem and has received £0.1 million in funding towards the project via the Government’s Local Growth Fund, secured by the Oxfordshire Local Enterprise Partnership (OxLEP).

 

Read the rest of entry »

Milton Park: Emergex Vaccines expands at Milton Park

Emergex Vaccines, which focuses on the development of synthetic T-cell vaccines against global infectious disease threats such as COVID-19, Dengue fever, Zika, Ebola and pandemic Flu, has expanded at Milton Park in Oxfordshire, one of Europe’s largest science and technology communities.

Read the rest of entry »

AMSBIO: Breast Cancer Cell Line Array 

AMSBIO announce a new HER2 control cell line array that was developed and is proven as an effective slide quality control for HER2 expression in breast cancer tissue samples.

This new FFPE cell pellet microarray delivers a full dynamic range of HER2, ER and PR expression, validated by the Ventana system, to give immunohistochemical data in strong concordance with the routinely processed tissue sample.sections.

Read the rest of entry »

Genomics plc completes oversubscribed $30m funding round

Genomics plc, a pioneering healthcare company that uses large-scale genetic information to develop innovative precision healthcare tools, is pleased to announce that it has successfully completed a $30m funding round.

Read the rest of entry »

WuXi AppTec Completes Acquisition of OXGENE to Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers

WuXi AppTec, a leading global provider of R&D- and manufacturing-enabling services in the pharmaceutical, biotechnology and medical device industries, today announced that it has completed the acquisition of OXGENE, a pioneering United Kingdom-based contract research and development organization that designs and develops scalable gene therapy technologies. This acquisition enables WuXi AppTec to offer its customers end-to-end support in the creation and development of cutting-edge cell and gene therapies for patients in need worldwide.

Read the rest of entry »

Isansys: New paediatric study concludes continuous wireless monitoring of infant sleep state at home

New paediatric study concludes continuous wireless monitoring of infant sleep state at home is a promising alternative to current methods due to its portability and access to high-resolution data

Read the rest of entry »

Phenotypeca raises £300,000 seed investment and strengthens its board

Phenotypeca has successfully raised £300,000 of seed investment from overseas and UK private investors to help grow the value of the business in 2021.  Ten new private investors from the US, EU and UK, are now providing Phenotypeca with global insight and a wealth of experience in the biopharmaceutical and business sectors.

Read the rest of entry »

ChromoTek and Absolute Antibody Collaborate on Recombinant Engineered Antibodies

ChromoTek GmbH, part of Proteintech specializing in Nanobody-based reagents, and Absolute Antibody Ltd., a leading provider of recombinant antibody technology, today announced a partnership to offer recombinant engineered antibodies to scientists worldwide. The chimeric antibodies were originally derived from alpaca Nanobodies and engineered onto mouse and rabbit Fc domains to open up new research applications. Available antibodies target key fluorescent proteins commonly used as tags for protein visualization, as well as the structural protein vimentin.

Read the rest of entry »

University of Birmingham spinout secures £800k for point of care diagnostics platform

Birmingham-based Linear Diagnostics Ltd has secured £800,000 from the Midlands Engine Investment Fund (MEIF) and other investors in the company’s second round of funding, which will enable the company to commence the development of the hardware platform for its tests.

Read the rest of entry »

Pages: Previous1234567...28NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.